Patients first diagnosed with advanced prostate cancer will now get immediate access to a drug which studies have shown can extend their life by more than a year compared to current options, NHS England has announced.

Two papers published on 16th December 2015 show that having early chemotherapy improves survival for men with prostate cancer.